HARVARD BIOSCIENCE, INC. Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years
HARVARD BIOSCIENCE, INC. (HBIO) had Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years of $4.40 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Expected Amounts › Defined Benefit Plan, Expected Future Benefit Payment
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter · last filed 2026-03-13
- 2025-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $4.40M.
- 2024-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $4.40M.
- 2023-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $5.00M.
- 2022-12-31: Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years $4.50M.
| Period end | Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years |
|---|---|
| 2025-12-31 | $4.40M 10-K · filed 2026-03-13 |
| 2024-12-31 | $4.40M 10-K · filed 2025-03-14 |
| 2023-12-31 | $5.00M 10-K · filed 2024-03-07 |
| 2022-12-31 | $4.50M 10-K · filed 2023-03-09 |
| 2021-12-31 | $4.80M 10-K · filed 2022-03-11 |
| 2020-12-31 | $4.70M 10-K/A · filed 2021-03-17 |
| 2019-12-31 | $4.20M 10-K · filed 2020-03-16 |
| 2018-12-31 | $4.00M 10-K · filed 2019-03-18 |
| 2017-12-31 | $4.20M 10-K · filed 2018-03-16 |
| 2016-12-31 | $3.60M 10-K · filed 2017-03-17 |
| 2015-12-31 | $4.00M 10-K · filed 2016-04-29 |
| 2014-12-31 | $4.70M 10-K · filed 2015-03-12 |
| 2013-12-31 | $4.60M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |